AGIO - Company ID 0001439222
The table below shows AGIOS PHARMACEUTICALS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $89.13M | $76.25M | $88.20M | $139.26M | $203.13M | $127.44M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | $32.92M | $27.62M | $19.08M | $8.49M | - | $14.70M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $942.05M |
| $965.60M |
| $833.84M |
| $832.77M |
| $1.06B |
| $636.68M |
| Property, plant & equipment | $10.78M | $11.68M | $15.38M | $22.99M | $28.92M | $32.29M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.30B | $1.66B | $937.12M | $1.24B | $1.44B | $852.95M |
| Accounts payable | $18.36M | $16.64M | $9.78M | $18.62M | $16.70M | $26.84M |
| Total current liabilities | $82.21M | $81.16M | $67.95M | $62.63M | $59.83M | $94.39M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $104.11M | $122.24M | $126.10M | $137.90M | $145.76M | $453.45M |
| Retained earnings | -$561.71M | -$148.92M | -$822.65M | -$470.56M | -$238.76M | -$1.84B |
| Total equity | $1.19B | $1.54B | $811.02M | $1.10B | $1.29B | $399.50M |